MREO - Mereo regains compliance with Nasdaq trading rule

2023-05-08 13:15:58 ET

• The U.K.-based biotech Mereo BioPharma ( NASDAQ: MREO ) announced Monday that the company regained compliance with the minimum bid price requirement under the Nasdaq Listing Rules.
• Mereo ( MREO ) said that the Nasdaq Stock Market officially notified on May 08 that the company is now in compliance with applicable listing standards for continued listing.
• The announcement comes after the MREO stock has traded at $1.00 or more for at least ten consecutive trading days leading up to May 05, 2023.
• In early November, Mereo ( MREO ) disclosed that it was not in compliance with Nasdaq listing rules after its American Depositary Shares (“ADSs”) failed to maintain a minimum bid price of $1.00 over the past 30 business days consecutively.

For further details see: